AP2008004602A0 - Melanocortin type 4 receptor agonist piperidinoylpyrrolidines - Google Patents

Melanocortin type 4 receptor agonist piperidinoylpyrrolidines

Info

Publication number
AP2008004602A0
AP2008004602A0 AP2008004602A AP2008004602A AP2008004602A0 AP 2008004602 A0 AP2008004602 A0 AP 2008004602A0 AP 2008004602 A AP2008004602 A AP 2008004602A AP 2008004602 A AP2008004602 A AP 2008004602A AP 2008004602 A0 AP2008004602 A0 AP 2008004602A0
Authority
AP
ARIPO
Prior art keywords
piperidinoylpyrrolidines
receptor agonist
melanocortin type
melanocortin
type
Prior art date
Application number
AP2008004602A
Other languages
English (en)
Inventor
Mark David Andrews
Alan Daniel Brown
Mark I Lansdell
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of AP2008004602A0 publication Critical patent/AP2008004602A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AP2008004602A 2006-02-23 2007-02-19 Melanocortin type 4 receptor agonist piperidinoylpyrrolidines AP2008004602A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77629506P 2006-02-23 2006-02-23
US88784007P 2007-02-02 2007-02-02
PCT/IB2007/000456 WO2007096763A2 (en) 2006-02-23 2007-02-19 Melanocortin type 4 receptor agonist piperidinoylpyrrolidines

Publications (1)

Publication Number Publication Date
AP2008004602A0 true AP2008004602A0 (en) 2008-10-31

Family

ID=38169450

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004602A AP2008004602A0 (en) 2006-02-23 2007-02-19 Melanocortin type 4 receptor agonist piperidinoylpyrrolidines

Country Status (22)

Country Link
US (1) US8138188B2 (xx)
EP (1) EP1989196B1 (xx)
KR (1) KR101036981B1 (xx)
AP (1) AP2008004602A0 (xx)
AU (1) AU2007219236B2 (xx)
BR (1) BRPI0708264A2 (xx)
CA (1) CA2642922C (xx)
CR (1) CR10219A (xx)
DK (1) DK1989196T3 (xx)
EA (1) EA200801738A1 (xx)
EC (1) ECSP088688A (xx)
ES (1) ES2402581T3 (xx)
HK (1) HK1126489A1 (xx)
IL (1) IL193279A (xx)
MA (1) MA30228B1 (xx)
ME (1) MEP6808A (xx)
MX (1) MX2008010899A (xx)
NO (1) NO20083480L (xx)
RS (1) RS20080371A (xx)
SG (1) SG185849A1 (xx)
TN (1) TNSN08337A1 (xx)
WO (1) WO2007096763A2 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2019100A1 (en) * 2007-07-19 2009-01-28 Santhera Pharmaceuticals (Schweiz) AG Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US8902867B2 (en) 2007-11-16 2014-12-02 Qualcomm Incorporated Favoring access points in wireless communications
US8848656B2 (en) 2007-11-16 2014-09-30 Qualcomm Incorporated Utilizing broadcast signals to convey restricted association information
US9603062B2 (en) 2007-11-16 2017-03-21 Qualcomm Incorporated Classifying access points using pilot identifiers
US8737295B2 (en) 2007-11-16 2014-05-27 Qualcomm Incorporated Sector identification using sector parameters signatures
EP2103614A1 (en) * 2008-03-18 2009-09-23 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators
US8588773B2 (en) 2008-08-04 2013-11-19 Qualcomm Incorporated System and method for cell search and selection in a wireless communication system
UA99555C2 (xx) 2008-11-12 2012-08-27 Элджи Лайф Саенсез Лтд. Агоністи рецептора меланокортину$агонисты рецептора меланокортина
EP2722045B1 (en) 2009-11-18 2016-07-06 Helsinn Healthcare SA Compositions for treating centrally mediated nausea and vomiting
GEP20156226B (en) * 2009-11-18 2015-01-26 Helsinn Healthcare Sa Ch Compositions for treating centrally mediated nausea and vomiting
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683705B1 (de) 2011-03-08 2015-04-22 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
WO2012120055A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120053A1 (de) 2011-03-08 2012-09-13 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP3333165B1 (en) 2015-08-04 2019-09-18 Astellas Pharma Inc. Piperazine derivative
IL298891A (en) 2020-06-09 2023-02-01 Pfizer Melanocortin 4 antagonists and use of preparations containing them
WO2023105387A1 (en) 2021-12-06 2023-06-15 Pfizer Inc. Melanocortin 4 receptor antagonists and uses thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (de) 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
GB8531071D0 (en) 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
US5274143A (en) 1991-07-23 1993-12-28 Hoffmann-La Roche Inc. Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
CA2098167C (en) 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
TW381025B (en) 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
US5596106A (en) 1994-07-15 1997-01-21 Eli Lilly And Company Cannabinoid receptor antagonists
DE4435477A1 (de) 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
BR9509436A (pt) 1994-10-27 1998-01-06 Janssen Pharmaceutica Nv Inibidores de síntese de apoliproteina-B
US5521186A (en) 1994-10-27 1996-05-28 Janssen Pharmaceutica N.V. Apolipoprotein-β synthesis inhibitors
WO2000035298A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Chewing gum containing medicament active agents
KR100652994B1 (ko) 1998-09-11 2006-11-30 아방티 파르마 소시에테 아노님 아제티딘 유도체, 이의 제조방법 및 이를 함유하는 약제
FR2789079B3 (fr) 1999-02-01 2001-03-02 Sanofi Synthelabo Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
DE60140693D1 (en) 2000-12-14 2010-01-14 Amylin Pharmaceuticals Inc Ankheiten
EP1383501B1 (en) 2001-02-28 2007-04-04 Merck & Co., Inc. Acylated piperidine derivatives as melanocortin-4 receptor agonists
EP1372653B1 (en) 2001-02-28 2006-10-04 Merck & Co., Inc. Acylated piperidine derivatives as melanocortin-4 receptor agonists
SI1373216T1 (en) 2001-03-22 2005-06-30 Solvay Pharmaceuticals B.V. 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
EP1585956A4 (en) 2001-09-24 2009-10-21 Univ Oregon Health & Science EVALUATIONS OF NEURONS IN THE ARQUE CORE FOR THE SCREENING OF AGENTS OF MODIFICATION OF FOOD BEHAVIOR
EP1482794A1 (en) 2002-03-06 2004-12-08 Merck & Co., Inc. Method of treatment or prevention of obesity
WO2004013120A1 (en) 2002-07-29 2004-02-12 F. Hoffmann-La Roche Ag Novel benzodioxoles
JP4667867B2 (ja) 2002-08-02 2011-04-13 メルク・シャープ・エンド・ドーム・コーポレイション 置換フロ［２，３−ｂ］ピリジン誘導体
US7129239B2 (en) 2002-10-28 2006-10-31 Pfizer Inc. Purine compounds and uses thereof
MY134457A (en) 2002-11-22 2007-12-31 Merck & Co Inc Substituted amides
US7329658B2 (en) 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
US7141669B2 (en) 2003-04-23 2006-11-28 Pfizer Inc. Cannabiniod receptor ligands and uses thereof
US7151097B2 (en) 2003-11-07 2006-12-19 Pfizer Inc. Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
GB0402492D0 (en) 2004-02-04 2004-03-10 Pfizer Ltd Pharmaceutically active compounds
CA2617654A1 (en) * 2005-08-04 2007-02-08 Pfizer Limited Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
CA2731897C (en) 2008-08-06 2013-07-02 Pfizer Limited Diazepine and diazocane compounds as mc4 agonists

Also Published As

Publication number Publication date
NO20083480L (no) 2008-09-10
IL193279A (en) 2012-12-31
TNSN08337A1 (fr) 2009-12-29
AU2007219236A1 (en) 2007-08-30
US20090036459A1 (en) 2009-02-05
ECSP088688A (es) 2008-10-31
CR10219A (es) 2008-09-23
KR20080095918A (ko) 2008-10-29
AU2007219236B2 (en) 2012-06-21
MEP6808A (xx) 2010-02-10
BRPI0708264A2 (pt) 2011-05-24
EP1989196A2 (en) 2008-11-12
MX2008010899A (es) 2008-11-27
KR101036981B1 (ko) 2011-05-25
SG185849A1 (en) 2012-12-28
EA200801738A1 (ru) 2008-12-30
RS20080371A (xx) 2009-07-15
DK1989196T3 (da) 2013-04-15
WO2007096763A3 (en) 2007-10-18
EP1989196B1 (en) 2013-02-13
MA30228B1 (fr) 2009-02-02
CA2642922A1 (en) 2007-08-30
US8138188B2 (en) 2012-03-20
WO2007096763A2 (en) 2007-08-30
IL193279A0 (en) 2009-02-11
ES2402581T3 (es) 2013-05-06
HK1126489A1 (en) 2009-09-04
CA2642922C (en) 2011-08-02

Similar Documents

Publication Publication Date Title
AP2008004602A0 (en) Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
HUS2100054I1 (hu) Melanokortin receptor ligandumok
EP2041120A4 (en) MELANOCORTIN RECEPTOR AGONISTS
EP2151236A4 (en) G PROTEIN COUPLED RECEPTOR AGONIST
IL200845A0 (en) Oligomer-opoid agonist conjugates
PT2018165E (pt) Compostos diméricos agonistas dos receptores dos fgf
EP2170064A4 (en) 6,5-pyrrolopiperidine tachykinin receptor antagonists
EP2017281A4 (en) AGONISTS AT TOLL-LIKE RECEPTOR 9
HK1131603A1 (en) Selective tr-beta 1 agonist
ZA200806992B (en) Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
GB0516946D0 (en) Receptor
IL198618A (en) Affluent acting on adenosine receptors
GB0623399D0 (en) Receptor
GB0623853D0 (en) Receptor
GB0608516D0 (en) Receptor
GB0604684D0 (en) Receptor
GB0522484D0 (en) Receptor
GB0522394D0 (en) Receptor
GB0522077D0 (en) Receptor
GB0510253D0 (en) Receptor